Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S.

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their ...

Medtronic (NYSE: MDT) announced today that it began the Embrace Gynecology  U.S. clinical study of its Hugo surgical robotic ...

Nearly 60 of the state’s biggest companies showcased their latest innovations, historical artifacts or community impact ...

The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its ...

Medtronic has doubled the size of its London office space and increased the site’s headcount to more than 200 to accelerate innovation in robotic surgery and AI-based product development. Located in ...

Surgical robotics is not a new phenomenon, but it's a space that continues to foster innovation across a range of ...

Belgium's AZ Maria Middelares is proud to take on a pioneering role as a technology-driven health care organization.